Lufang Zhou Selected Research

Adenosine Triphosphatases (ATPase)

1/2017	Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy.
1/2014	Inhibiting Na+/K+ ATPase can impair mitochondrial energetics and induce abnormal Ca2+ cycling and automaticity in guinea pig cardiomyocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lufang Zhou Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 10/2014
8	Ischemia 01/2022 - 05/2005
4	Triple Negative Breast Neoplasms 01/2022 - 01/2021
4	Myocardial Infarction 01/2022 - 01/2019
3	Heart Failure 01/2021 - 01/2014
3	Left Ventricular Dysfunction 01/2020 - 03/2015
3	Myocardial Ischemia (Ischemic Heart Diseases) 08/2014 - 09/2008
2	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 01/2022
2	Reperfusion Injury 01/2022 - 08/2014
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2017
2	Cardiac Arrhythmias (Arrythmia) 01/2018 - 01/2014
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Infarction (Infarctions) 01/2022
1	Infections 01/2022
1	Body Weight Changes 07/2021
1	Meningioma (Meningiomas) 05/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Hypertrophy 01/2021
1	Heart Diseases (Heart Disease) 10/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Neuroblastoma 10/2017
1	Alzheimer Disease (Alzheimer's Disease) 10/2017

Drug/Important Bio-Agent (IBA)

6	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2018
5	Monoclonal AntibodiesIBA 03/2024 - 01/2018
3	muconomycin AIBA 12/2023 - 11/2020
3	Maytansine (Maitansine)IBA 08/2021 - 11/2020
3	somatostatin receptor 2IBA 05/2021 - 11/2020
3	mitoquinoneIBA 01/2020 - 03/2015
3	AntioxidantsIBA 01/2020 - 03/2015
3	Lactic Acid (Lactate)FDA LinkGeneric 09/2008 - 05/2005
2	Gemcitabine FDA Link 08/2021 - 07/2021
2	Y 27632IBA 10/2019 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 10/2014
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 01/2014
2	Adenosine Triphosphate (ATP)IBA 10/2009 - 10/2006
2	malic acid (malate)IBA 09/2008 - 10/2006
2	Aspartic Acid (Aspartate)FDA Link 09/2008 - 10/2006
2	NAD (NADH)IBA 10/2006 - 06/2005
1	LuciferinsIBA 03/2024
1	monomethylauristatin FIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	LuciferasesIBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Beclin-1IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Long Noncoding RNAIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Chemokine ReceptorsIBA 11/2020
1	romidepsin (FK228)FDA Link 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Vorinostat FDA Link 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 10/2017
1	beta-Arrestin 2IBA 10/2017
1	AntigensIBA 10/2014
1	GlycosidesIBA 01/2014
1	Cardiac GlycosidesIBA 01/2014
1	PotassiumIBA 10/2009
1	EnzymesIBA 09/2008
1	Insulin (Novolin)FDA Link 09/2008
1	CarbohydratesIBA 09/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2008
1	Nonesterified Fatty Acids (NEFA)IBA 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	Pyruvic Acid (Pyruvate)IBA 05/2005
1	GlycogenIBA 05/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2008
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
1	Bioreactors (Bioreactor) 11/2020
1	Lasers (Laser) 01/2020
1	Cell Transplantation 10/2019
1	Transplantation 01/2019
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 08/2014
1	Ligation 08/2014